Suicide is a devastating public health issue that imposes severe psychological, social, and economic burdens not only for the individuals but also for their relatives, friends, clinicians, and the general public. Among the different suicidal behaviors, suicide completion is the worst and the most relevant outcome. The knowledge of biological etiopathological mechanisms involved in suicide completion is limited. Hitherto, no objective markers, either alone or in combination, can reliably predict who will complete a suicide. However, such parameters are strongly needed to establish and optimize prediction and prevention.
Introduction
The World Health Organization (WHO) estimated for 2012 that a person died from suicide every 40 s on average worldwide (WHO, 2014a) . Suicidal behaviors entail devastating consequences for the individuals, their families, friends, and the community. They also heavily burden clinicians (Séguin et al., 2014) . Some healthcare professionals even refuse to offer treatment to suicidal subjects or stop treatment when the patients report suicidality (Hawgood and De Leo, 2016) . Clinicians and other healthcare providers face the challenge of estimating an individual's risk for suicidal behavior in the immediate future. The major problem is that until today, objective markers for the prediction of completed suicides have not been sufficiently reliable (Large et al., 2017) . The available demographic and clinical parameters lack acceptable predictive accuracy; thus, clinicians are forced to trust their intuition. Additionally, knowledge of the etiopathogenetic mechanisms underlying suicidal behaviors is severely limited. It is scarcely possible to reliably identify risk cohorts and successfully develop and establish target group-specific prevention programs.
We introduce the ideation-to-completion framework in suicide research here and explain why it is important to meticulously differentiate between suicidal ideation, suicide attempts, and suicide completion. In the process of identifying reliable prediction markers, it is highly relevant to reveal the bio-psycho-social mechanisms that are specifically implicated in suicide completion. The gender paradox of suicidal behaviors (see Section 5.1) and the interactions between androgens, aggressive, violent, and impulsive behaviors, and suicide completion suggest that androgens are involved in the pathogenesis of death by suicide. We present direct and indirect evidence showing that both prenatal (= "organizational," including permanent -psychological susceptibilities (=distant risk factors) to predict suicidal behaviors (Ludwig et al., 2017; Mann et al., 1999) . The distant risk factors include but are not limited to genetic, developmental, and psychological burdens (e.g., inadequate nutrition, trauma exposure, childhood adversity) with long-lasting behavioral and neurobiological changes (e.g., epigenetic and other functional alterations).
Genetic variations in the serotonin neurotransmitter system, the hypothalamic-pituitary-adrenal (HPA) axis, reactive aggression, and impaired cognitive control are known contributors to the vulnerability (van Heeringen and Mann, 2014 ). An aggregate heritability estimate of approximately 45% as a predisposing diathesis has been reported for completed suicides (Mirkovic et al., 2016; Voracek and Loibl, 2007) . Genetic polymorphisms of tryptophan hydroxylases and serotonin receptors and transporters are associated with suicidal behaviors in a plethora of studies. Also variants in dopaminergic and adrenergic signaling, HPA axis activity, and neurotrophic processes (e.g., brain derived neurotrophic factor (BDNF)) predispose to suicidal behaviors (for review Ludwig et al., 2017; Mirkovic et al., 2016) . Interestingly, the intronic rs1800532 polymorphism of the tryptophan hydroxylase gene was shown to be protective against death from suicide in males younger than 35 years and in females older than 50 years; by contrast it tended to be a risk factor in elderly male subjects (Buttenschøn et al., 2013) . Such gene x sex x age interactions might explain why suicide rates are highest among elderly males in some ethnicities. Furthermore, genome wide association studies have revealed novel candidate genes that need to be further investigated (Ludwig et al., 2017) ; notably, neurodevelopmental and androgen-activity related genes appear to be involved in suicidal behaviors (Sokolowski et al., 2016a,b) .
There is emerging evidence that stressors, including early-life adversities such as childhood abuse, entail lasting neuronal epigenetic modifications with consecutively impaired gene expression and function (Labonte and Turecki, 2010; Labonte et al., 2012; McGowan et al., 2009; Turecki et al., 2012; Zhang et al., 2013) . This is thought to contribute to suicide vulnerability. Studies found dysregulated promoter methylation in GABAergic, polyaminergic, and neurotrophic systems and the HPA axis in postmortem suicide brain tissue. Some investigations also show that these epigenetic alterations are associated with changes in gene expression (e.g., for BDNF (Keller et al., 2010) , spermidine/spermine N 1 -acetyltransferase 1 (Fiori and Turecki, 2011) , and the glucocorticoid receptor (Labonte et al., 2012) ) (for review Ludwig et al., 2017; Zhang et al., 2013) . In summary, several neurobiological factors such as genetics, early in life-induced epigenetic and functional alterations of neuronal activity, and stress responsiveness predispose individuals to react with suicidal behaviors when confronted with acute stressors.
Suicide prediction
Suppose you are a clinician responsible for a hospitalized, severely depressed patient with suicidal ideation. How high is the risk of active suicidal behavior for this patient in the next few weeks? What questions should you ask the patient? Is it at all possible to predict future suicidal acts at a clinically meaningful level? When analyzing the literature to answer these questions, it is important to consider the time horizon (short-term vs. long-term prediction), the issue of prediction (suicidal ideation vs. suicide attempt vs. suicide completion), the study population investigated (e.g., general population, psychiatric inpatients), and the study type (e.g., exploration, validation) .
This section presents a short overview of the knowledge regarding individual risk factors. Moreover, it summarizes several salient problems in predicting future suicidal behaviors and current approaches to overcoming these problems. We describe the ideation-to-action framework and introduce a novel ideation-to-completion framework in suicide research.
Frequently cited risk factors
Although many potential markers for suicidal behaviors have been described in previous research, their clinical use is strongly limited because specific predictors of the most relevant clinical outcomesuicide completion -are still lacking. The WHO (2014a) states that "suicidal behaviour is a complex phenomenon that is influenced by several interacting factors-personal, social, psychological, cultural, biological and environmental." Against this background, a multitude of individual risk factors have been tested for their suitability to predict whether individuals will develop suicidal behavior.
The following aspects have been suggested by the WHO (2014a). The risk of suicide is increased by a previous suicide attempt or a deliberate act of self-harm (odds ratio [OR] = 16.33) and a family history of suicide (OR = 2.58) . Moreover, it is assumed that approximately 90% of subjects who die from suicide suffer from a mental illness (Cavanagh et al., 2003; Hawton and van Heeringen, 2009 ). For example, the ORs for suicide completion reach 13.42 in subjects with mood disorders , 9.8 in subjects with posttraumatic stress disorder (PTSD) , 7.98 in subjects with alcohol use disorders , and 5.24 in subjects with substancerelated disorders . Acute stress reaction (Gradus et al., 2010b) and adjustment disorder (Gradus et al., 2010a) relate to a more than 10-fold increased risk for suicide completion. . The secondary analyses also demonstrated a significant intervention effect on the number of attempted suicides but not on the number of completed suicides (Hegerl et al., , 2010 . Notably, Pfeiffer et al. (2009) found in depressed veterans an increased risk for suicide completion in those with anxiety disorders (panic disorder, adjusted OR = 1.26, generalized anxiety disorder, adjusted OR = 1.27, anxiety disorder, not otherwise specified, adjusted OR = 1.25) and a reduced risk in those with PTSD (adjusted OR = 0.87). Thus, the relationships of mental illnesses with suicidal behaviors must not be overgeneralized and need to be further scrutinized. It has been shown that, for example, depression and addictive disorders differ regarding their impact on suicidal behaviors as illustrated in detail in the next sections. Finally, chronic pain and hopelessness (=a pessimistic view of the future; e.g., measured by the Beck Hopelessness Scale) Brezo et al., 2006; Brown et al., 2000; O'Connor and Nock, 2014) are also associated with an increased risk of suicide. Nevertheless, all of these markers, either alone or in combination, cannot sufficiently predict at useful clinical levels who will actually complete suicide, which has been criticized for a long time (e.g., Brown and Shearan, 1972; Carter et al., 2017; Large et al., 2017) .
Methodological limitations
For several reasons, it has been, and still remains, difficult to establish reliable predictors for suicide completion: the hitherto absence of specific predictors for suicide completion, the low total probability of the occurrence of completed suicides, and the difficulty in finding such cases (Cohen, 1986; Murphy, 1984) . As noted above, 90% of the subjects who complete suicide suffer from a mental illness, particularly depression, substance use disorders, and schizophrenia (Cavanagh et al., 2003; Hawton and van Heeringen, 2009) . Even in psychiatric inpatients with a strongly increased risk for suicide and even when using a hypothetical test for predicting suicide with extremely low rates of false positives and false negatives, the accuracy of the test would not exceed 20% (MacKinnon and Farberow, 1976) . It is also important to consider the difference between retrospective and prospective studies. Retrospective exploratory studies analyzing many attributes that either alone or in combination explain suicidal behaviors usually yield overly optimistic estimates compared to studies that aim to prospectively validate a predefined prediction model with clear criteria and cut-off values. These difficulties derived from theoretical considerations agree well with the empirical studies. Predictors for psychiatric inpatient suicide derived from a meta-analysis (Large et al., 2011b ) include a family history of suicide, a history of deliberate self-harm, and hopelessness. Patients suffering from both schizophrenia and a depressed mood are at particular risk. High-risk categorization based on retrospectively determined risk factors was strongly associated with inpatient suicide (OR = 10.9). However, prospective studies of outcomes in highrisk groups are still required. Furthermore, the low incidence of inpatient suicides makes it difficult to prevent suicide completion through the categorization of some patients into high-risk groups. A recent meta-analysis shows that due to a lack of an adequate positive predictive value no available high-risk classification is clinically useful (Carter et al., 2017) . It is also interesting to note that some risk factors identified in the general population were not significantly associated with inpatient suicide in the meta-analysis (e.g., male gender OR = 1.20, lower to upper limit, 0.90-1.60) (Large et al., 2011b) . Another meta-analysis of controlled studies of suicide within one year of discharge from a psychiatric hospital found no single factor or combination of factors that were strongly associated with suicide and that risk categorization was of only limited value (Large et al., 2011a) . A recent meta-analysis on the suicide risk assessment among psychiatric patients shows that the frequently used separation of psychiatric patients into high-risk and low-risk patients lacks a sufficient empirical basis. The pooled OR of completed suicides was 4.84 in the high-risk patients compared to the lower-risk patients. However, there was evidence of a publication bias towards the selective reporting of studies with a stronger effect size. The between-study heterogeneity was high, and the more recent studies were not better at predicting suicide completion compared to the older studies. The authors conclude that suicide risk categorization based on multiple risk factors does not greatly exceed the association between single suicide risk factors and suicide (Large et al., 2016) . A recent meta-analysis supports the view that high risk classification based on available biological measures or psychological scales is clinically not useful (Carter et al., 2017) .
A similar conclusion was drawn from the analysis of patients who presented themselves in an emergency room after self-harm. The risk of repetition of self-harm was classified as low, moderate, or high. The risk of repetition of self-harm within 12 months was highest in the high-risk group. However, the predictive value of risk assessment was low. Many repeaters were in the low and moderate groups. Psychiatrists were only slightly better than the emergency staff in predicting the repetition of self-harm. Exclusive high risk approaches to intervention are therefore unlikely to succeed (Kapur et al., 2005) .
Ideation-to-action framework
It is important to keep in mind that suicidality represents a continuum from suicidal ideation to suicide attempt and further to suicide completion. At least 95% of suicide attempters report previous suicidal ideation (for review, see May and Klonsky, 2016) , and every completed suicide represents a lethal suicide attempt. Therefore, risk factors identified in studies that compared non-suicidal subjects with suicide completers need to be interpreted cautiously. Hitherto, the extent to which each of the frequently cited parameters distinguishes between non-suicidal subjects and suicidal ideators, between suicidal ideators and suicide attempters, and between suicide attempters and suicide completers remains widely unknown. The following example illustrates the problem: Let us assume that a specific risk factor differentiated between non-suicidal individuals and suicide completers in a large representative study. The lack of cautiousness may now entail the interpretation that the risk factor is a specific predictor of suicide completion in suicide attempters, which is an important goal in the daily clinical routine. However, this interpretation may be false and the risk factor useless because the risk factor may differentiate more strongly between non-suicidal subjects and suicide attempters (which is a prerequisite of suicide completion) and not sufficiently between suicide attempters and suicide completers. Thus, it is particularly important to meticulously differentiate between non-suicidal subjects, suicide ideators, suicide attempters, and suicide completers in future research.
Most of the previous research does not properly differentiate between ideation and action. In a large cross-national sample of 17 countries from all continents (WHO World Mental Health Survey Initiative (WHO World Mental Health Survey Consortium, 2004) ), the lifetime prevalence of suicidal ideation, plans, and attempts is 9.1, 3.1, and 2.7%. However, results from similar studies vary strongly which is due to different measurement methods. Estimates for lifetime suicidal ideation range from 3.1 to 56.0%, for lifetime suicide plans from 0.9 to 19.5%, and for lifetime suicide attempts from 0.4 to 5.1% (Nock et al., 2008b) . Among suicide ideators, the probability of ever making a suicide plan is approximately 34% and of ever making a suicide attempt is 29% (Nock et al., 2008a) . The pooled analysis revealed that the risk of suicidal ideation, plans, and attempts was significantly related to being female (ORs ≥ 1.4), younger (ORs 18-34 years ≥9.5, 35-49 years ≥4.2, 50-64 years ≥2.6; reference category 65+ years), having fewer years of formal education, and before being married (ORs ≥ 1.3). In the total sample, the presence of psychiatric disorders dose-dependently increased the risk for suicidal ideation, plans, and attempts (two disorders ORs ≥ 1.9, three disorders ORs ≥ 6.1); the strongest diagnostic risk factors in high-income countries were mood disorders (ORs = 4.7-5.9; for comparison: anxiety disorders 3.4-4.8, impulsecontrol disorders 3.3-4.2, substance use disorders 2.8-4.2) (Nock et al., 2008a) . These risk factors for ideation, plans, and attempts were also found in a large cohort in the United States of America. Importantly, all significant risk factors were more strongly related to ideation, plans, and attempts than to the progression from ideation to a plan or an attempt (Kessler et al., 1999) . Similarly, prior traumatic experiences dosedependently result in increased risk for ideation but do not predict the progression from ideation to a plan or an attempt (Stein et al., 2010) . These studies show that most suicide ideators do not attempt suicide. When looking more closely, it appears that most of the previously identified risk factors, such as major depressive disorder, predict significantly ideation but not or more weakly attempts among individuals considering suicide (Borges et al., 2008; Nock et al., 2010) . Therefore, suicidal ideation and suicidal attempts should be related to separate risk factors, which has been highlighted by the ideation-to-action framework (Klonsky and May, 2014; Klonsky et al., 2016; May and Klonsky, 2016) . A meta-analysis of twelve potential factors that distinguish non-suicidal individuals from suicide ideators identified several variables such as depression, PTSD, and hopelessness. In contrast, depression and hopelessness had only a negligible to moderate effect in distinguishing ideators from attempters . A similar result was found in a large cross-national survey (Nock et al., , 2012 . Moreover, a 12-year follow-up study failed to show that hopelessness predicted suicide completion in suicide attempters (Suominen et al., 2004) and a meta-analysis found no evidence for an increased risk of completed suicide in individuals with PTSD . Accordingly, adoption studies have shown a genetic predisposition for suicidal behavior that is partially independent of the presence of a mental illness (Roy, 1983; Zalsman, 2012) . In conclusion, it is necessary to identify separate risk factors for suicidal ideation and suicidal actions.
Ideation-to-completion framework
The ideation-to-action framework suggests focusing on factors predicting the transition from suicidal ideation to suicidal action (attempts and completion) in future research. This advancement falls short; for a number of reasons, a low-lethality suicide attempt is something completely different when compared to a completed suicide. First, the frequency is different: compared to suicide attempts, the frequency of completed suicides is very low. For every suicide, 20 suicide attempts are estimated (WHO, 2014a) . Second, the age distribution is different. A consistent risk factor for suicide attempts in individuals considering suicide is being young. Although the association between age and suicide rate varies strongly between the different regions, in most countries, completed suicides peak in older persons. Third, the gender distribution is different. Suicidal ideation and suicide attempts occur more frequently in females with an even higher OR for attempts compared to ideation (Kessler et al., 1999; Nock et al., 2008a,b; Weissman et al., 1999) . By contrast, completed suicides occur more frequently in males, particularly in high-income countries (WHO, 2014a) . Fourth, the consequences are different: Although non-lethal and even low-lethal suicide attempts can cause injury, such as suffering, disability, and shame for the affected individual, completed suicides have different and much more severe consequences not only for the individuals but also for their families, friends, and society. After a suicide attempt, the individual's life continues and can be positively influenced by therapy. A completed suicide is a final act that does not allow any further intervention. For healthcare providers, therefore, the main task is to predict and prevent the most severe event, which is a completed suicide.
The age and gender distributions separate ideation from completion but not ideation from low-lethality action. This shows that the difference between ideation and low-lethality action is small compared to the difference between ideation/attempts and completion. A recent metaanalysis was not very successful in differentiating adults who have attempted suicide and survived from those who have only considered suicide but never made an attempt . The reason for the previous inability to predict suicidal action in individuals who consider suicide may be that the concept of "ideation-to-action" is too broad because it includes low-lethality action. As argued above, there are important differences between suicide attempts and completed suicides. It might be more successful and it is more important to identify the differences between ideators and completers. Future studies should therefore address the transition from "ideation-to-completion."
It should also be mentioned that suicide completion may occur unexpectedly. No or only minor suicidal ideation does not ultimately exclude suicide completion. However, it was shown that suicidal ideation is absent in less than 5% of suicide completers (for review, see May and Klonsky, 2016) . Certainly, more research into this phenomenon is needed.
Another important facet in psychiatric treatment is the assessment of suicidality within the following few days and weeks. Surprisingly little is known regarding the factors that predict suicide completion within the near future (Cassells et al., 2005; Glenn and Nock, 2014) . While severe hopelessness, suicidal ideation, and a history of previous suicide attempts predicted suicides occurring after one year, other clinical features such as severe anxiety and insomnia were associated with suicide within one year .
Most suicide completers suffer from a mental illness (Cavanagh et al., 2003; Hawton and van Heeringen, 2009) . We now discuss the role of different psychiatric disorders in suicidal behaviors against the background of the ideation-to-completion framework in suicide research. Meta-analyses have shown that depressive disorders (d = 0.85) and depression severity (d = 0.90) may better differentiate between non-suicidal subjects and suicide ideators than between suicide ideators and suicide attempters (d = 0.24, d = 0.23) . A history of psychiatric contact also does not significantly predict the transition from self-harm to suicide (adjusted hazard ratio (HR) = 1.27, 95% confidence interval (CI) 0.94-1.73) (Chan et al., 2016 ). In contrast, substance use disorders are superior in differentiating between suicide ideators and suicide attempters (alcohol d = 0.31, drugs d = 0.49) and alcohol misuse predicts the transition from self-harm to suicide (although it is only marginally significant; adjusted HR = 1.63) (Chan et al., 2016) . In depressed male patients, suicides are related to the 6-month diagnosis of alcohol abuse/ dependence (OR = 3.16) and drug abuse/dependence (OR = 3.42) but not significantly to an anxiety disorder (OR = 1.89, 95% CI 0. 71-5.17) . It is also worth mentioning that cluster B personality disorders (borderline, antisocial, narcissistic, histrionic) are associated with an increased risk for suicide completion in depressed male patients (OR = 28.0) . In addition, the male gender is associated with an adjusted HR of 2.05 for a completed suicide in people with a history of self-harm (Chan et al., 2016) . This indicates that markers related to addictive disorders and male gender may be more specific in predicting suicide completion than those linked to depression.
Summary
It is currently not possible to identify who will ultimately complete a suicide at clinically sufficient levels. This results in the statement "suicide is preventable but not predictable" (Large and Nielssen, 2012) and underlines the necessity of objective and reliable predictive markers. The deficiency also limits the development and establishment of target group-specific prevention programs. Nearly all negative aspects of life increase suicidal behavior. We acknowledge that chance also plays an important part in suicide (aleatory uncertainty) (Large et al., 2017) . Most of the well-known risk factors, such as depression, are mostly associated with suicidal ideation but do not sufficiently differentiate between ideation and action. According to our ideation-tocompletion framework, future suicide research should focus on the transition from suicidal ideation to suicide completion to identify the specific factors that can predict who will prospectively complete a suicide. The meta-analyses suggest that male gender and substance use disorders represent parameters that are more specifically associated with suicide completion, which is why we continue to review additional male and androgen activity-related factors such as aggression, violence, and impulsivity in the following sections.
Androgen-related individual risk factors of suicide
The male gender and male-specific behavioral traits are related to death by suicide. This suggests that androgen activity is involved in the pathogenesis of suicide completion (=androgen model of suicide completion) and that the androgen activity-related markers may be useful for specifically predicting suicide completion. In this section, we discuss gender, violence, aggression, impulsivity, and the concepts of male depression and mixed depression in the context of suicidal behaviors.
Gender paradox of suicide
Female gender is a risk factor for suicidal ideation, plans, and attempts (Kessler et al., 1999; Nock et al., 2008a; Weissman et al., 1999) . The influence of gender on suicidality becomes clearer when differentiating low-lethality attempters, high-lethality attempters, and completers: the proportion of males continuously increases from low-lethality attempters to completers (DeJong et al., 2010) . Accordingly, the WHO reports a global male-to-female ratio of 1.9 with age-standardized suicide rates of 15.0 per 100,000 males and 8.0 per 100,000 females. Moreover, an even higher male-to-female ratio in high-income WHO Member States of 3.5 with age-standardized suicide rates of 19.9 per 100,000 males and 5.7 per 100,000 females has been estimated (WHO, 2014a) . Suicide occurs more frequently in males, whereas suicidal ideation, plans, and attempts are more prevalent in females. This phenomenon is called the gender paradox of suicide, which may be explained with different bio-psycho-social reasons. Males choose more lethal suicide methods than females, suicidal males exhibit higher levels of intention to die than females, and the same suicide methods are more likely to be fatal when conducted by men compared to women (Mergl et al., 2015) . Further mechanisms underlying the higher rates of transition from suicidal ideation to suicide completion in men than in women include expectations for managing stress and conflict, substance use patterns, and care-seeking behaviors for mental illness (Canetto and Sakinofsky, 1998) .
Male behaviors of violence, aggression, and impulsivity
Androgen activity and male gender are clearly associated with violence, aggression, and impulsivity (Archer, 1991; Bettencourt and Miller, 1996; Carré et al., 2017; Cross et al., 2011; Giammanco et al., 2005; Nelson and Trainor, 2007; Zell et al., 2015) . Suicide completion may be understood as an extreme form of self-aggression, and we suggest that it follows higher androgen activity and brain masculinization. Engström et al. (1999) found temperamental similarities of violent offenders with suicide attempters. The assessment of violence and aggression is informative in the prediction of suicide (Gvion and Apter, 2011; Stefansson et al., 2015) . A meta-analysis found a small but significant association of impulsivity with suicide attempts and completed suicides . Impulsivity consists of several facets of the personality: urgency, lack of perseverance, lack of premeditation, and sensation seeking (Whitheside and Lynam, 2001 ). Depressed male patients who complete suicide differ from living agematched depressed male patients by higher levels of impulsivity and aggression. It is speculated that a developmental cascade may start with a biological predisposition to higher levels of impulsive and aggressive behaviors . Furthermore, epidemiological and genetic studies show that suicidal behavior runs in families via the transmission of impulsive aggression (Bondy et al., 2006; Brent and Mann, 2005; Brent and Melhem, 2008; Kovacsics et al., 2009 ). Importantly, the disposition for impulsive aggression may play a role in increasing the risk of the subsequent development of a mood disorder (Brent et al., 2015) . This sequence, namely aggression leading to depression, is further supported by longitudinal studies on oppositional defiant disorder (Burke, 2012; Hipwell et al., 2011) . Violence and aggression have differentiated suicidal ideation from action in previous studies Joiner et al., 2009; . Parental antisocial personality (associated with impulsive aggression) and anxiety disorders predict the onset and persistence of suicide attempts among ideators (Gureje et al., 2011) .
The male behavioral traits of aggression, violence, and impulsivity relate to suicide attempts and suicide completion. Their relationship to testosterone corroborates the role of androgen activity in suicide attempts and suicide completion.
Antisuicidal lithium and clozapine effects and aggression
Further evidence for the central role of the male behavioral trait of aggression in suicide comes from pharmacological studies showing that lithium decreases the risk of suicide completion probably via the reduction of aggression. The first hints of an antisuicidal effect of lithium emerged in early trials in the 1970s (Coppen et al., 1971; Prien et al., 1973a,b) and continued to appear later in randomized controlled studies, in long-term follow-up studies of lithium-treated patients, and in a discontinuation study. Lithium in drinking water also appears to exert antisuicidal effects (for references, see Lewitzka et al., 2015; Vita et al., 2015) . A placebo-controlled randomized study investigated the effects of lithium treatment on suicidal behaviors as primary outcomes and showed a lower rate of completed suicides in the lithium group, while there was no difference in suicide attempts . Baldessarini et al. (2006) conducted a meta-analysis of 31 reports identified by a broad literature search (also including open clinical studies and randomized controlled trials with suicidal events as nonprimary outcomes) and found that lithium reduced the risk of suicidal acts for both attempted and completed suicides. This meta-analysis also found a reduced lethality of suicide attempts under lithium treatment. A recent meta-analysis confirms that lithium reduces the risk of suicide completion . Lithium was more effective than the placebo in reducing the number of suicides (OR 0.13) and deaths from any cause (OR 0.38) in mood disorders. However, lithium showed no clear benefits compared to a placebo in preventing deliberate self-harm.
Which intermediate phenotypes are involved in the antisuicidal effects of lithium? The mood-stabilizing effect of lithium results in fewer or less severe depressive episodes and therefore should reduce depression-linked suicidal behavior. However, there is evidence that the antisuicidal effect of lithium is independent from the mood-stabilizing effect: A similar reduction in suicide attempts was observed in patients with good effects as well as in patients with limited effects of lithium on affective episodes ). Compared to lithium, antidepressant drugs usually exhibit stronger antidepressant effects. Nevertheless, their antisuicidal effect is inferior to lithium, which indicates a specific antisuicidal effect of lithium that is independent of the mood-stabilizing or antidepressant effects. Lithium use results in lower levels of aggression, both in animals and humans, which could also reduce suicidal behavior. Strong evidence in humans for the effect of lithium on aggression comes from double-blind, placebo-controlled prospective studies in adults; one of these was performed in a crossover design (Sheard et al., 1976; Worrall et al., 1975) . Lithium also reduces impulsivity (e.g., Ohmura et al., 2012) . However, the evidence is not as strong compared to aggression (for references, see reviews and meta-analyses, Comai et al., 2012; Jones et al., 2011; Kovacsics et al., 2009; Müller-Oerlinghausen and Lewitzka, 2010) .
Which mechanisms mediate the antisuicidal effects of lithium on a molecular level? Lithium affects several molecular targets such as the G-protein receptor coupling or intracellular calcium signaling, signal transduction systems, and oxidative metabolism. It also exerts antiapoptotic properties (for review, see Jope, 1999; Malhi et al., 2013) . Multiple lines of evidence indicate that stress-induced inflammation is of particular interest. Vulnerability phenotypes leading to suicidal behavior, namely aggression, impulsivity, and depression, are all linked to inflammation. Lithium lowers stress-induced inflammation by inhibiting glycogen synthase kinase 3 (for a review, see Beurel and Jope, 2014) .
Some evidence suggests that the atypical antipsychotic drug clozapine also reduces the risk for suicide attempts and completed suicides (Meltzer and Okayli, 1995; Meltzer et al., 2003; Walker et al., 1997) . Similar to lithium, this effect may be explained by clozapine's properties to reduce violent and aggressive behaviors (Frogley et al., 2012) .
Taken together, lithium and clozapine treatments reduce the risk of completing suicide. This effect is most likely independent of mood stabilization and may be mediated by the modulation of aggression and impulsivity, which are predominantly male behaviors.
Depression
Depression is a risk factor for suicide with an adjusted HR of 2.0 in the 90 days after hospital discharge . Because women are reported to be affected approximately 2-3 times more often by a major depressive disorder than men (Kessler et al., 1993; Weissman et al., 1993) , one might expect more suicides in women than in men. Thus, the global male-to-female ratio of 1.9 for suicides (WHO, 2014a) is counter-intuitive and needs to be addressed further. As discussed in Section 4, major depressive disorder, according to the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD), is a better predictor of suicidal ideation than the transition from suicidal ideation to a suicide attempt or completed suicide.
There is evidence suggesting that depression and alcohol dependence overlap and/or interact to influence suicide completion. A high co-morbidity of depressive episodes and alcohol use disorders has been reported in subjects who had died by suicide, and high ORs for suicide completion have been found in individuals who suffered from both depression and substance use disorders (for review, see ). Moreover, depression, alcohol use disorders, and suicide share common genetic variants suggesting similar underlying molecular pathways. For example, the short allele of the 5-hydroxytryptamine transporter-linked polymorphic region (5HTTLPR) increases the risk for depression (Clarke et al., 2010) , alcohol dependence (McHugh et al., 2010; Oo et al., 2016) , and suicide completion (for review Mirkovic et al., 2016) . This genetic variant also associates with higher medical damage (Wasserman et al., 2007) and violence (Neves et al., 2010) in suicide attempters and with increased lethality among suicide attempters aged over 40 years .
The higher suicide risk in males compared to females, the counterintuitive relationship to depression, and the overlap of depression and alcohol dependence in the context of suicide completion indicate the existence of different forms of depression. Indeed, depression is a highly heterogeneous disorder and the concepts of male depression and mixed depression might provide explanations to the contradictories. They include traits such as aggression, impulsivity, and risky behaviors all of which are related to androgen activity (Piacentino et al., 2015) .
Male depression
The empirical evidence for a higher prevalence of depression in females compared to males is questioned. It is hypothesized that depressive disorders in males are underdiagnosed (Gallacher and Klieger, 1995; Kiecolt-Glaser and Newton, 2001; Mirowsky and Ross, 1995; Möller-Leimkühler et al., 2007; Verbrugge, 1989) . The model of male depression was established mainly after findings within the framework of a suicide prevention program on the Swedish island of Gotland (Rutz et al., 1995; Wålinder and Rutz, 2001 ). This project revealed that suicide prevention in patients with depressive disorders reduced only the female suicide rate. Male depression is specifically characterized by more irritability, aggression, alcohol consumption, agitation, rage attacks, and antisocial behavior, all of which may be related to androgen activity (Fava et al., 1995; Katz et al., 1993; Kockler and Heun, 2002; Möller-Leimkühler, 2009; Winkler et al., 2004 Winkler et al., , 2005 . It was speculated that a consideration of the diagnostic and therapeutic male specificities may entail a reduction in male suicides (Rutz, 1999) . The male depression syndrome as presented by Wålinder and Rutz (2001) included symptoms and circumstances such as low stress tolerance, acting out, poor impulse control, substance abuse, a family history of depression, alcohol use disorders, and suicidality. Affected men report the classical depressive symptoms less frequently than women (Angst et al., 2002) . To optimize the diagnostic procedure, the authors developed the Gotland Scale for Male Depression (Rutz, 1999) . More recent studies provide further support for the concept of the male depression syndrome (Angeletti et al., 2013; Azorin et al., 2014) .
Although the etiopathological mechanisms underlying the male depression syndrome remain largely unknown today, androgen activity is most likely involved. Compared to women, men are generally more focused on their social status (e.g., men desire professional advancement more strongly than women (Gino et al., 2015) ) and are more sensitive to psychobiological stress, leading to higher vulnerability to socio-economic strain (Möller-Leimkühler, 2003 Troisi, 2001) . Men respond to negative emotional stress more often with externalizing strategies such as substance use, aggression, risk taking, and consecutive endangerment to the self or others (Möller-Leimkühler, 2009 ). Anger represents a negative emotion that men are permitted to show (Fields and Cochran, 2010) . It is hypothesized that this behavioral pattern is a result of socialization processes as well as conformity to the masculine norms of male autonomy, invulnerability, and stoicism (Möller-Leimkühler, 2009; Rice et al., 2013; Rutz, 2001 ). Interestingly, stoicism has been linked to the acquired capability for suicide . High conformity to masculine norms is also linked to poorer mental health in general and a lower likelihood of seeking psychological assistance, which are determinants of vulnerability to and resilience against suicide. Among the different dimensions of masculine norms, winning, emotional control, violence, "playboy" behaviors, self-reliance, and desire for power over women correlate positively with negative mental health and negatively with seeking psychological assistance. Moreover, negative mental health is linked to greater risk-taking, dominance, and pursuit of status. Less seeking of psychological assistance is associated with disdain for homosexuals (Wong et al., 2017) . The listed male reaction patterns may be biologically determined, as they may be influenced by androgens. It is worth mentioning that the male depression pattern can also be seen among women, which consolidates the idea of the biologically determined component, e.g., androgen activity, within the etiopathogenesis. Koukopoulos et al. (1992) observed that some patients with depression also present psychic excitation but do not fulfill the criteria for a mixed episode of bipolar disorders. They suggested terming this clinical phenomenon as mixed depressive syndrome. Further research has supported the concept (Angst et al., 2011; Azorin et al., 2012; Benazzi, 2000 Benazzi, , 2003 Benazzi, , 2007 . With the publication of the 5th edition of the DSM in 2013, the American Psychiatric Association (2013) introduced the mixed features specifier. It allows the classification of individuals who fulfill the criteria for a major depressive episode and who simultaneously show subthreshold symptoms of (hypo)mania such as grandiosity, talkativeness, flight of ideas, increase in energy, and excessive activities with painful consequences. Additionally suggested diagnostic criteria include irritability, emotional lability, psychomotor agitation, anger and aggression, inner tension, impulsivity, and risky behaviors. Up to one third of patients with major depressive episode show a mixed state (Perugi et al., 2015; Stahl et al., 2017) .
Mixed depression
Symptoms of mixed depression were reported to be associated with suicidal ideation . Patients with mixed depression have a higher risk for suicide attempts in comparison to patients with pure depression and in comparison to patients with a lifetime history of purely manic episodes without mixed features . Moreover, Sani et al. (2011) provide evidence that mixed depression symptoms might also predict completed suicides. In their follow-up sample of 4441 psychiatric patients, 96 completed suicide. 54.2% of the suicide victims had suffered from inner tension, 53.1% from racing/crowded thoughts, 31.2% from aggressive behavior, and 30.2% from psychomotor agitation. Notably, the authors also report that shorter-term treatment with lithium or anticonvulsants and longer-term treatment with antidepressants predicted suicide completion supporting the antisuicidal effects of lithium. A careful assessment and management of suicidality in patients with mixed depression is advised (Dubois et al., 2013) .
There is reason to assume that androgens are involved in mixed depression and suicide (for review Piacentino et al., 2015) . In a randomized, placebo-controlled, crossover trial, administration of testosterone cypionate for 6 weeks entailed hypomanic scores and aggressive responses in males aged 20-50 years; 12% became at least mildly hypomanic (Young Mania Rating Scale (YMRS) score 10-19) and 4% markedly hypomanic (YMRS score ≥ 20) (Pope et al., 2000) . Another 2-week, double-blind, placebo-controlled, crossover trial showed that high-dose methyltestosterone induced euphoria, energy, sexual arousal, irritability, mood swings, violent feelings, and hostility. One out of 20 males developed an acute manic episode and another study subject became hypomanic (Su et al., 1993) . Moreover, plasma testosterone levels were shown to correlate positively with the number of previous manic episodes and suicide attempts in bipolar patients .
Summary
The gender paradox of suicidal behaviors, the roles of violence, aggression, and impulsivity in suicide completion, and the antisuicidal effects of lithium (probably via the reduction of aggression) suggest that androgen effects specifically facilitate suicide completion. Furthermore, the commonly used definitions of depression are not able to reliably predict individuals who will complete a suicide; by contrast, the concepts of male depression and mixed depression relate to phenotypes such as aggression, impulsivity, and risky behaviors (all of which, incidentally, are influenced by androgen activity); thus, these concepts may be more informative in predicting future suicide compared to the common ICD and DSM classifications of depressive disorders.
Androgen activity and suicide
Androgens may cause both permanent and transient effects on brain activity. Especially during intrauterine development, androgen exposure influences cerebral organization with long-lasting neuroadaptations, causing permanent effects on cerebral function and adult behaviors (= organizational androgen effects). Importantly, prenatal androgen exposure induces brain masculinization in both genders and thus entails individual differences in maleness and femaleness within each gender. Of course, this exposure does not alter the sex-specific karyotype. In addition, androgens directly activate the brain's function in a reversible manner (= activational androgen effects) (Lenz et al., 2012) .
Organizational androgen effects
To our knowledge, no studies have been published until today that have directly measured androgens during the prenatal window and investigated their effects on suicidal ideation, suicide attempts, or suicide completion later in life. Thus, we review studies here using biomarkers and models for prenatal androgen exposure to demonstrate that the prenatal androgen load relates to an increased risk for suicide later in life. We also present data suggesting that prenatal androgen activity is not significantly related to suicidal ideation or suicide attempts. This observation prompts us to assume that the prenatal androgen load is a relatively specific predictor of suicide completion. Moreover, we argue that maternal factors during pregnancy contribute to the offspring's prenatal androgen load. This indicates that specific maternal behaviors may be useful as future targets of suicide prevention.
6.1.1. Second-to-fourth finger length (2D:4D) ratio During the intrauterine episode, androgens determine the development of digit cartilages. The second-to-fourth finger length (2D:4D) ratio is a biomarker for prenatal androgen exposure. Lower 2D:4D ratios indicate a higher prenatal androgen load, and higher 2D:4D ratios suggest a lower prenatal androgen load. Accordingly, most studies show lower 2D:4D ratios in males than in females; further lines of indirect clinical and direct preclinical evidence verify the validity of the 2D:4D ratio as a biomarker for intrauterine androgen load on the cohort level (for a review, see Berenbaum et al., 2009; Manning et al., 2014; Talarovičová et al., 2009; Zheng and Cohn, 2011) . However, the 2D:4D ratio is not a sufficiently accurate marker for individual differences in prenatal androgen exposure (Berenbaum et al., 2009) .
Intrauterine androgen load not only determines finger length growth but also influences brain development. Lower 2D:4D ratios in both the right and left hands are considered a proxy for masculinized brain organization. Although some studies show stronger associations between 2D:4D ratio and the target traits for the right hand (e.g., Bilgic et al., 2016; Hönekopp and Watson, 2010; Kornhuber et al., 2011; Manning et al., 1998; Masuya et al., 2015) , others found stronger effects for the left hand (e.g., Kilduff et al., 2013; Kornhuber et al., 2013; Lu B. Lenz et al. Progress in Neurobiology 172 (2019) 84-103 et al., 2015) . To our knowledge, there is no reliable explanation for differing associations of right and left hand 2D:4D ratios with prenatal androgen load.
In a recent study, we found significantly lower (masculinized) 2D:4D ratios in male suicide corpses in comparison to male non-suicide corpses with medium to large effect sizes (Fig. 1) . This observation indicates that a higher prenatal androgen load and related masculinized brain organization increase the risk of male individuals completing suicide in adulthood; i.e., prenatal hyperandrogenization facilitates suicide completion ).
We also provide national level evidence for a role of the 2D:4D ratio in suicide completion. A cross-national comparison of 23 countries revealed that (after normalization to the national mean of males and females) the national male 2D:4D ratios correlated negatively with the national male suicide rates. This means that lower (prenatally more androgenized) national male 2D:4D ratios (divided by the national mean of the male and female values) were found in countries with a higher risk for suicide in males (divided by the national mean of the male and female values) .
According to the ideation-to-completion framework, the identification of predictors specific to suicide completion is highly relevant. Thus, we investigated whether the 2D:4D ratio also relates to suicidal thoughts and/or suicide attempts. In an online survey, we gathered quality-checked data on 2D:4D ratios and lifetime history of suicidal thoughts and suicide attempts in 2316 SoSciPanel members (www. soscisurvey.de). Altogether, the 2D:4D ratio was not significantly associated with suicidal thoughts or suicide attempts in the cohort despite the large number of study subjects (Fig. 2) .
In summary, there is evidence that a lower 2D:4D ratio, which indicates prenatal hyperandrogenization, is a relatively specific risk factor for suicide completion in males. However, future studies are needed to investigate whether the 2D:4D ratio also differs between suicide attempters who survived and suicide completers. We will now discuss the potential behavioral mediators of the relationship between the 2D:4D ratio and completed suicide, such as aggression, sensation seeking, substance use disorders, cognitive reflection, and socio-cognitive performance.
6.1.1.1. Aggression. Lowered 2D:4D ratios in subjects who died by suicide are in accordance with higher aggression in suicide completion because lower 2D:4D ratios correlate with higher aggression, although this association was reported to be weak in the general population (Hönekopp and Watson, 2010) . It is important to mention that testosterone levels rise prior to challenges (Mazur and Booth, 1998) . Accordingly, the link between aggression and 2D:4D ratios depends on the context with weaker correlations in neutral laboratory settings and stronger associations in challenging situations with androgen spikes (Manning et al., 2014) . Kilduff et al. (2013) provide evidence that the 2D:4D ratio moderates the relationship between aggressive stimuli and reactive aggression. Moreover, Romero-Martínez et al. (2013) found lower 2D:4D ratios in intimate partner violence perpetrators compared to control subjects. Interestingly, the perpetrators' right hand 2D:4D ratios correlated negatively with the testosterone response following a stress condition. We speculate that challenging situations with related androgen spikes are relevant to the suicide etiopathogenesis, particularly in subjects with low 2D:4D ratios. Future studies are needed to elucidate the exact mechanisms underlying the association between the prenatal androgen load and adult androgen activity in challenging situations such as a prenatal androgen exposure-induced lower threshold for stimulation of androgen production and/or increased androgen sensitivity.
6.1.1.2. Sensation seeking. It is assumed that the male behavioral trait of sensation seeking as a facet of impulsivity contributes to the gender dimorphism in suicide completion via the psychological construct of acquired suicide capability. This model includes fearlessness of death and, indirectly, suicidal intent . In accordance with the assumption of prenatal hyperandrogenization in suicide completion, the extent of sensation seeking correlates negatively with the 2D:4D ratio (Hampson et al., 2008) . We found significantly lower 2D:4D ratios in male suicide corpses (n = 32) compared to male non-suicide corpses (n = 15). This observation suggests that higher prenatal androgen exposure increases the risk for later suicide in male subjects. 2D:4D ratios did not significantly differ between female suicide corpses (n = 14) and female non-suicide corpses (n = 10) (http://creativecommons.org/licenses/by/4.0/). The graph shows marginal means ± standard errors of the mean. 2D:4D second-to-fourth finger length ratio. *p < 0.05, ns not significant.
(caption on next page) B. Lenz et al. Progress in Neurobiology 172 (2019) [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] 6.1.1.3. Substance use disorders. Psychological autopsy studies report that 15 to 63% of people who complete suicide have suffered from a substance use disorder ). Additionally, a recent metaanalysis shows that substance use disorders relate to increased ORs for suicidal ideation, suicide attempts, and suicides of 2.04, 2.49, and 1.49, respectively . Regarding alcohol use disorders, ORs > 2.5 were estimated for both suicide attempts and completed suicides . Alcohol use accounts for 22% of all global deaths from self-harm (WHO, 2014b) and 13% of disabilityadjusted life years caused by suicides (Ferrari et al., 2014) . Moreover, alcohol dependence is related to a lifetime suicide risk of 7% . This strong association between alcohol use disorders and suicide completion points to a common pathophysiological mechanism. Independent studies have shown lower 2D:4D ratios in patients suffering from alcohol dependence in comparison to healthy control subjects (Han et al., 2016; Kornhuber et al., 2011; Lenz et al., 2017) . Together with further indirect evidence from biomarkers of prenatal androgen load including transient evoked otoacoustic emissions and age at onset of puberty, this suggests that prenatal organizational androgen effects predispose the development of alcohol dependence in adulthood (for review, see Lenz et al., 2012 Lenz et al., , 2017 . Thus, intrauterine hyperandrogenization appears to contribute to an array of adult male physiological and pathological traits that also include alcohol dependence and suicide completion. Soon after onset, affective disorders and schizophrenia relate to higher suicide risks that decline subsequently; by contrast, the suicide risk of alcohol-dependent patients remains stable throughout the individual's lifetime . This observation supports the view that an increased prenatal androgen load with lifelong permanent neuroadaptations represents a common pathophysiological mechanism in the etiopathogenesis of both alcohol dependence and suicide completion. , 2014) . Applied to the ideation-to-completion framework of suicide, this indicates that the impulse to immediately escape from a current unfavorable situation is overridden more effectively in persons with lower 2D:4D ratios. This may lead to more carefully planned suicide attempts, which are more likely to be fatal (Dombrovski et al., 2011) . Stronger cognitive reflection may also entail the previously reported greater intention to die in suicidal men than in suicidal women (Mergl et al., 2015) . Furthermore, androgen effects reduce socio-cognitive performance in males, as testosterone administration was demonstrated to attenuate the "Reading the Mind in the Eyes Task" results in subjects with low 2D:4D ratios (Carré et al., 2015) . This is interesting because Rasmussen et al. (2014) explored the history of ten young men who completed suicide and found no signs of previous mental disorders but found evidence for an underdeveloped capacity to regulate emotions such as anger in challenging situations.
Handedness
In addition to the 2D:4D ratio, handedness is another biomarker for organizational (prenatal) androgen effects (Cohen-Bendahan et al., 2005; Geschwind and Galaburda, 1985; Wisniewski, 1998; Witelson, 1985) , although handedness is less conclusive than the 2D:4D ratio because it is also influenced by sex hormone activation later in life (Lenz et al., 2012) . Males are more likely to be left-handed (PapadatouPastou et al., 2008) . Therefore, the report of higher rates (30%) of lefthanders in male suicide victims compared to the general male population (approximately 12% (Peters et al., 2006; Ruebeck et al., 2007) ) supports the view that masculinized brain organization (following prenatal hyperandrogenization) is a risk factor for suicide. Additional evidence comes from transgender identity which is related to both left-handedness (Green and Young, 2001 ) and increased risk for suicide attempts and suicide completion (Clements-Nolle et al., 2006; Haas et al., 2011; Mereish et al., 2014; Mustanski and Liu, 2013; Mustanski et al., 2010; Peterson et al., 2017) .
Congenital adrenal hyperplasia
The autosomal recessive disorder congenital adrenal hyperplasia is seen as a model for the adolescent and adult effects of a higher prenatal androgen load. The disease exposes affected individuals to increased Fig. 2 . No significant association of the 2D:4D ratios with suicidal thoughts or suicide attempts. The quality-checked cohort of the online survey included in total 1135 males and 1181 females (www.soscisurvey.de; survey period: June and July 2016; exclusion criteria: premature discontinuation, did not state having answered honestly or repeated participation, SoSci score of data quality "DEGRADE" > 200; for further details of the study design see . The participants were instructed to self-measure their 2D:4D ratios similarly to the method described by Reimers (2007) . Each subject was asked (A) whether he or she had ever experienced concrete thoughts to take his or her own life or to complete suicide and, if this question has been answered in the affirmative, (B) whether he or she had ever attempted suicide. We assumed that individuals, who had denied concrete lifetime suicidal thoughts (question A), had also never attempted suicide. Subjects with a high risk of inaccurate 2D:4D ratio measurement (e.g., technical problems, finger deformities, < 2.5 or > 97.5 sex-specific percentiles) or missing data regarding suicidal thoughts were not included in the statistical models. The analyzed study cohort consisted of 917 males and 957 females and was characterized by a mean age of 38.1 years (standard error of the mean 0.3; median 34.0, interquartile range (IQR) 26.0-49.3), a BMI > 25 kg/m 2 in 42.0% of the participants, probable alcoholdependence (≥2 positive CAGE screening questionnaire criteria for alcohol use disorders (Ewing, 1984) with a self-report of a previous health care contact due to an addictive disorder) in 0.4%, possible alcohol-dependence (≥2 positive CAGE criteria without a self-report of a previous health care contact due to an addictive disorder) in 10.0%, and no alcohol-dependence (≤1 positive CAGE criterion) in 89.6% of the study subjects. We found a lifetime history of suicidal thoughts in 30.2% and suicide attempts in 4.5% of the participants (n = 25 did not answer whether or not they have attempted suicide before). In their crossnational epidemiological review, Nock et al. (2008b) detected widely varying prevalence estimates between 3.1 and 56.0% for lifetime suicidal ideation and between 0.4 and 5.1% for lifetime suicide attempts. We used a statistical approach similar to the description of Lenz et al. (2016) : repeated measure analyses of variance (ANOVA) adrenal androgens and steroid precursors during intrauterine development and relates to lower 2D:4D ratios (Brown et al., 2002; Ökten et al., 2002) . In accordance with a role of androgens in suicide, males with congenital adrenal hyperplasia are at an increased risk for suicidal behavior (attempted and completed suicide combined, OR = 2.3) . Affected females suffer more often from suicidal thoughts than control subjects .
Body mass index
Body mass index (BMI) is associated with suicide completion. In a recent meta-analysis, being underweight is significantly related to an increased risk of completed suicide (HR = 1.21) and both obesity and overweight to decreased risks (HRs = 0.71 and 0.78). Interestingly, the authors found no clear association between BMI and suicidal ideation or suicide attempts . At first glance, this protective effect of a higher BMI against suicide is counterintuitive because of the well-established stigma of obesity (Sikorski et al., 2011 ) and because of a higher risk for depression in obese persons (adjusted ORs ≥ 1.19) (Jokela et al., 2014) . However, this negative association between BMI and risk for suicide becomes clearer when considering the effects of prenatal hyperandrogenization on suicide completion. Positive correlations between 2D:4D ratios and BMI have been reported (Fink et al., 2003; statistical trend, Oyeyemi et al., 2014) . Thus, the relationship between lower BMI values and suicide completion may further support the role of increased prenatal androgen exposure in suicide later in life.
Early developmental factors
Thus far, the extent to which maternal androgen levels and/or fetal androgen activity contribute to increased prenatal androgen exposure in suicidal behavior remains largely unknown. Some indirect evidence from 2D:4D ratio, birth order, maternal age, infant birth weight, and sex differences suggests, but by no means confirms, that higher maternal androgen levels and some modifiable maternal behaviors during pregnancy increase the risk for later suicide completion in the offspring.
First, there is a negative correlation between the maternal second trimester plasma testosterone levels and the newborns' right hands 2D:4D ratios (Ventura et al., 2013) . Moreover, several studies show a positive correlation between the number of older siblings and risk for suicide. In Finland, an elevated suicide risk of 1.27 in second-born, 1.35 in third-born, and 1.72 in fourth or higher birth order subjects was reported . Accordingly, an increase in birth order was linked to an 18% higher risk in a Swedish cohort , to a 46% higher risk in an Norwegian cohort , and to a trend for a higher risk in a British cohort . There is some indirect evidence that may suggest that prenatal androgen effects are involved in this relationship. In males, a higher number of older brothers was associated with lower 2D:4D ratios (Saino et al., 2006; Williams et al., 2000) . Higher birth order increases the likelihood and the phenotype for other higher prenatal androgen exposure-related adult behaviors, such as substance use disorders (Barclay et al., 2016; Han et al., 2016; Keltner et al., 1986; Kornhuber et al., 2011; Lenz et al., 2017) , autism spectrum disorders (Baron- Cohen et al., 2015; Martin and Horriat, 2012) , and elite sports activities (Hopwood et al., 2015; Manning and Taylor, 2001) . Furthermore, multipara are less likely to reduce smoking during pregnancy (Lehmann et al., 2012) and to breastfeed their babies (Buckles and Kolka, 2014) in comparison to unipara. Both maternal behaviors may be linked to increased children's prenatal androgen exposure because maternal smoking during pregnancy correlates with an increased androgen load in the offspring (proxy: 2D:4D ratios) (Lenz et al., 2017; Rizwan et al., 2007) , and women with higher midgestational androgen levels are less likely to breastfeed their babies (Carlsen et al., 2010) . In addition, studies report a higher risk for suicide in subjects with younger mothers Geoffroy et al., 2014; Niederkrotenthaler et al., 2012) and in subjects with lower birth weights Niederkrotenthaler et al., 2012) . Again, these associations are in accordance with our prenatal hyperandrogenization model of suicide completion because younger maternal age correlates with higher testosterone levels during pregnancy Troisi et al., 2008) and higher testosterone levels predict lower offspring birth weight (Carlsen et al., 2006) . It is also important to note that birth order, maternal age, and infant birth weight were not significantly associated with suicidal ideation in a large longitudinal British birth-cohort study supporting the assumption that early androgen activity-related factors might be more specific to suicide completion than suicidal ideation.
Furthermore, human and experimental evidence shows that maternal androgen activity prior to and around conception influences the children's sex ratio, with higher androgen activity resulting in more male offspring (Gharagozlou et al., 2016; James, 2015) . Adult conditions that follow increased prenatal maternally derived androgen exposure should thus be more prevalent in males than in females, which is in accordance with the well-established higher rate of completed suicides in males than in females (WHO, 2014a) . Against this background, we also expected a rise in the male-to-female suicide ratio in the last several decades because of increasing rates of obesity (Poston et al., 2016) and gestational diabetes (Fadl and Simmons, 2016; Lavery et al., 2017) , conditions that are associated with greater female androgen activity (Sutton-Tyrrell et al., 2010; Uzelac et al., 2010) . To test this hypothesis, we calculated the male-to-female suicide ratios for the years 2000 and 2012 using the WHO sex-specific age-standardized suicide rates of 171 member states with populations of 300,000 or more (Annex 1 in WHO, 2014a). In accordance with our expectations, the median of the national male-to-female suicide ratios increased from 2.84 (IQR 2.11-3.77) in 2000 to 2.96 (IQR 2.28-4.00) in 2012 (Wilcoxon signedrank test, Z = −2.1, p = 0.03). We acknowledge that the evidence reported here is based on associations. Future research is needed to confirm underlying causality.
Summary
There is converging evidence from the 2D:4D ratio, handedness, congenital adrenal hyperplasia, BMI, birth order, birth weight, maternal androgen levels, maternal age, and sex differences that a higher prenatal androgen load and subsequent masculinized brain organization (following prenatal hyperandrogenization) are associated with increased risk of suicide completion in adulthood. Consequently, we believe that hitherto neglected neurodevelopmental aspects contribute to the risk for suicide completion. We did not find a significant association of the 2D:4D ratios with suicidal thoughts or suicide attempts in a large online survey and thus speculate that the 2D:4D ratio may function as a predictor specific to suicide completion. As such, the 2D:4D ratio might be a useful instrument for clinicians and other healthcare providers in the future. However, further studies are certainly needed to verify the utility in clinical use. It is also important to mention that the assumption that prenatal hyperandrogenization with permanent neuroadaptations predisposes individuals to suicide may also explain why the rate of completed suicides does not decrease with age in most countries as with the gonadal androgen production.
Furthermore, aggression, substance use disorders, cognitive reflection, and socio-cognitive performance may represent behavioral mediators of the prenatal androgen effect on suicide completion. Finally, early developmental factors and related maternal androgen activity appear to contribute to the children's prenatal androgen load. This warrants future research on the specific behaviors of pregnant women that determine fetal androgen exposure to develop effective preventive strategies. Associational studies indicate that maternal smoking behavior, alcohol consumption, and perceived stress during pregnancy may represent effective targets to modify the offspring's intrauterine androgen load and to consequently reduce the risk for suicide completion in later life (Barrett and 
Activational androgen effects
Several lines of evidence indicate that androgen levels in adulthood directly influence suicidal behaviors. Although women attempt suicide more often, men are more likely to die by suicide (=gender paradox of suicidal behavior); some suicidologists suggest that the differences in adult peripheral androgen levels between men and women account for the sexual dimorphism in suicide rates (e.g., Lester, 1993) . Violence, impulsivity, and aggression are associated with suicidal behaviors, and it is assumed that the serotonergic system is involved in this relationship (Apter et al., 1993; Mann, 2003; Zalsman, 2012) . Thus, studies relating testosterone, serotonin signaling, and aggression to each other (Birger et al., 2003; Kranz et al., 2015; Kuepper et al., 2010; Walderhaug et al., 2007 ) also indicate that androgens may directly affect suicidal ideation, suicide attempts, and suicide completion. As already introduced in Section 6.1.1, there is some evidence suggesting a potentiating interaction between the prenatal androgen load (2D:4D ratio as a proxy) and adult androgen levels (related to challenging situations (Manning et al., 2014) ), which may also be relevant for suicide completion.
Gonadal androgens
In this section, we review direct and indirect evidence demonstrating that adult androgen activity relates to suicide attempts and suicide completion at different levels of the hypothalamic-pituitarygonadal (HPG) axis.
6.2.1.1. Direct evidence. Increased peripheral serum testosterone levels have been found in male suicide corpses in comparison to sudden death corpses . Higher plasma testosterone levels have also been shown in male and less strongly in female suicide attempters in comparison to community controls . A recent study reported higher plasma and cerebrospinal fluid (CSF) testosterone levels in male suicide attempters compared to the controls and a positive relationship between the CSF testosterone/cortisol ratio and both impulsivity and aggressiveness . Accordingly, CSF testosterone levels correlated positively with irritability and aggression in males with cluster B personality disorders following a suicide attempt (Gustavsson et al., 2003) . These results may indicate that impulsivity and aggressiveness mediate the relationship between adult testosterone levels and suicide completion. Moreover, plasma testosterone levels correlated positively with the number of previous suicide attempts in male and female patients with bipolar disorder and predicted future suicide attempts in females with bipolar disorder in a prospective study . In male veterans suffering from PTSD, higher levels of the neurosteroid dehydroepiandrosterone (DHEA), an endogenous precursor of androgens, were found in suicide attempters (Butterfield et al., 2005) . Again, Perez-Rodriguez et al. (2011) found higher plasma testosterone levels in the recruited 112 male suicide attempters (Mean = 5.54 ng/ml, standard deviation (SD) = 2.80) compared to the 37 male healthy controls (blood donors; mean = 4.76 ng/ml, SD = 1.97), although this difference failed to reach significance. However, lowered blood testosterone levels in males following suicide attempt in comparison to healthy controls have also been reported .
In conclusion, the only available study on this topic shows an association between increased serum testosterone levels and suicide completion, whereas the results regarding androgen levels in suicide attempts are inconsistent. In accordance with our androgen model of suicide completion, this may indicate that activational androgen activity is more specific to suicide completion than other suicidal behaviors. However, testosterone reduction after a suicide attempt, observed by Tripodianakis et al. (2007) , could also be explained by a stress-related interaction with the HPA axis (Zitzmann and Nieschlag, 2001 ). For future studies, it will be important to consider the time interval between the suicide attempt and testosterone measurement.
Furthermore, cortical hypertrophy of the adrenal glands was found in suicide corpses (9 men, 3 women) in comparison to sudden death non-psychiatric controls (17 men, 5 women) (Szigethy et al., 1994) . Because the adrenal cortex produces glucocorticoids (zona fasciculate) and androgens (e.g., DHEA; zona reticularis), this finding suggests longlasting alterations of the HPG and the HPA axes in subjects who have died by suicide. There is also first direct evidence for an impaired feedback mechanism of the HPG axis in male suicide attempters. In their study, Markianos et al. (2009) found no increase of luteinizing hormone despite lowered serum testosterone levels following suicide attempts.
6.2.1.2. Indirect evidence. The following sections provide indirect evidence for the role of activational androgen activity in suicidal behaviors.
6.2.1.2.1. Circadian, seasonal, lifetime, and ethnic patterns. Circadian and seasonal fluctuations of suicide rates parallel adult androgen levels, which supports the role of adult androgens in suicide completion. A peak of completed suicides is reached in the morning and a nadir occurs in the late evening. This effect appears to be stronger in males than in females Preti and Miotto, 2001; ); by contrast, deliberate self-harm peaks between 10 pm and midnight . Testosterone levels are higher in the morning than in the evening (Crawford et al., 2007; Smith et al., 2013) . The circadian association between suicide completion and higher testosterone levels in the morning and the dissociation from deliberate self-harm, which is more likely to happen in the late evening when testosterone levels are low, support our assumption that androgen activity may be involved in facilitating suicide completion and that androgen activity-related parameters may represent predictors that are more specific to suicide completion and less relevant to suicidal ideation, deliberate self-harm, or suicide attempts. In addition, there is a seasonal peak of completed suicides in the late spring and during the summer months in both genders for the northern hemisphere and in December for the southern hemisphere Petridou et al., 2002) which co-occurs with higher testosterone levels and higher testosterone/estradiol ratios during the spring and summer in studies with samples from the northern hemisphere (Andersson et al., 2003; Demir et al., 2016; Moskovic et al., 2012) . In accordance with the role of aggression in the androgen model of suicide completion, Preti and Miotto (1998) found clear evidence of seasonality with a peak in the spring only for violent suicides but not those using non-violent methods (analysis of all suicides registered in Italy from 1984 to 1995).
At first glance, the decline of bioavailable testosterone levels over the life span in men and women (Bhasin et al., 2018; Fabbri et al., 2016) contradicts the observation of an increase of suicide risk with increasing age. However, the association between age and the suicide rate varies strongly between different countries. It is beyond doubt that cultural aspects influence this association (WHO, 2014a) . A higher suicide risk with increasing age may be explained as follows: It was suggested that lowered testosterone levels may also increase the risk of suicide due to higher vulnerability to depression (Sher, 2013a,b) , and it should also be mentioned here that testosterone replacement therapy may exert antidepressant effects in hypogonadal men (Amanatkar et al., 2014) . In addition, we speculate that the male depression and mixed depression phenomena and prenatal androgen-driven brain organization are involved (as discussed in Section 5.4). Moreover, some countries show a peak in the suicide rate in the third decade of life (WHO, 2014a) , which parallels the peripheral testosterone levels. It is also important to note that with increasing age, the suicide rate shows a course similar to peripheral testosterone levels in black but not white Americans, i.e., a peak during the third life decade and a steady decline afterwards . This may suggest that black Americans are more vulnerable to the activational androgen effects in terms of suicide compared to white Americans. We speculate that sensitization due to intrauterine hyperandrogenization underlies this ethnic difference because of higher maternal testosterone levels in black women compared to white women during pregnancy (Henderson et al., 1988) and subsequent higher prenatal androgen loads in black individuals compared to white individuals .
6.2.1.2.2. Menstrual cycle. Total and free testosterone levels are higher during the follicular phase compared to the luteal phase of the menstrual cycle (Linton et al., 2016) . Leenaars et al. (2009) found in their histopathological study that 25% of women who had completed suicide were menstruating (=beginning of the follicular phase) compared to 4.5% of the control group. Suicide attempts occur also more frequent than expected during the follicular phase . These observations link an increased suicide risk to higher testosterone levels. Moreover, premenstrual dysphoric disorder (PMDD) is associated with suicidal ideation, plans, and attempts in a United States cohort (adjusted ORs ≥ 2.10) (Pilver et al., 2013) and in a Korean cohort (adjusted ORs > 3.72) (Hong et al., 2012) . Accordingly, a high percentage of female inpatients suffer from premenstrual syndrome (PMS; 50% (Ducasse et al., 2016) ) and PMDD (23% (Ducasse et al., 2016) , 54% (Baca-Garcia et al., 2004) ) after a suicide attempt, and interestingly, these women are characterized by increased impulsive-aggressive personality traits. As far as we know, the suicide rate in women with PMS or PMDD has not yet been studied. However, higher free testosterone levels were found in women with PMS compared to women without PMS in the luteal and the follicular phases and around ovulation (Eriksson et al., 1992) . The co-occurrence of an increased risk of suicidal behaviors and higher androgen levels in women with premenstrual symptoms further corroborates the role of androgens in suicide.
6.2.1.2.3. Cigarette smoking and alcohol use disorders. A recent metaanalysis reports ORs of 2.05 for suicidal ideation, 2.36 for suicide plans, 2.84 for suicide attempts, and 1.83 for suicides in current smokers . We interpret the fact that smoking is associated with suicidal behaviors as further indirect evidence for the role of adult androgen activity because a meta-analysis reported higher testosterone levels in male smokers compared to male non-smokers (Zhao et al., 2016) and because several studies show that nicotine inhibits CYP19A1 activity (aromatization of androgens into estrogens) in the brain (Biegon et al., 2010) , trophoblast (Barbieri et al., 1986) , and breast tissues (Kadohama et al., 1993) .
It is also important to mention that among subjects with alcohol use disorders, middle-aged men (35-54 years of age) are even more vulnerable to suicide (OR = 14.0) than older men (OR = 5.8) ). This may suggest that adult androgen activity is also involved in the association between alcohol dependence and suicide in middle age.
6.2.1.2.4. Anabolic-androgenic steroids. Anabolic-androgenic steroids (AAS) such as testosterone and its synthetic derivatives are mostly used by males. Human and animal data show that AAS use increases aggressive and impulsive behaviors involving different neurotransmitters such as vasopressin, serotonin, and dopamine (Morrison et al., 2016; Onakomaiya and Henderson, 2016) . The abuse of AAS is associated with premature death (Pärssinen et al., 2000; Petersson et al., 2006) , and it has been shown that a high ratio of all AAS-related deaths is linked to violence. In accordance with the assumption that androgen activity predisposes one to suicide completion, AAS are proposed as increasing the suicide risk (Trenton and Currier, 2005) . AAS intake was suggested to explain the increased suicide rates of former Swedish male elite athletes who were active from 1960 to 1979 (Lindqvist et al., 2014) and Finnish powerlifters who were active in national championships from 1977 to 1982 (Pärssinen et al., 2000) . The use of AAS is associated with suicide attempts in United States high school students . Moreover, high rates of suicides were found in AAS-related deaths. Suicides were reported to account for 16.7% of 24 AAS-related deaths in Sydney and for 32.4% of 34 AAS-related deaths in Stockholm . Interestingly, Thiblin et al. (1999) found in their cohort of eight males who completed suicide and had a history of AAS use that only one individual experienced suicidal ideation before beginning the intake of AAS. This observation suggests a causal role of AAS use in suicidal attempts and suicide deaths and indicates that androgens may entail completed suicides independent of prior suicidal ideation. AAS increase aggressive and impulsive behaviors and may facilitate suicide completion without initial suicidal ideation.
Summary
Direct (blood, CSF) and indirect (circadian, seasonal, and lifetime fluctuations, menstrual cycle, smoking behavior, alcohol use disorders, and AAS) evidence shows that high androgen levels and an impaired HPG feedback mechanism may increase the risk of suicide attempts and suicide completion. The behavioral traits of aggression and impulsivity appear to mediate this relationship, at least in part. It might be interesting for future studies to investigate the interactions between androgen levels, androgen responsiveness and androgen sensitivity in challenging situations, 2D:4D ratios, other biomarker for prenatal androgen load, impulsivity, aggression, and suicidal behaviors.
The hypothalamic-pituitary-adrenal (HPA) axis and early-life stress
A dysregulation of the HPA axis plays a critical role in suicidal behavior and some evidence suggests that early-life stress and sex hormone activity are involved.
Non-suppression in the dexamethasone suppression test predicts suicide completion in depressed patients with a history of attempted suicide (Jokinen et al., , 2008 and in depressed patients in general ). Non-suppression or early cessation of dexamethasone suppression was observed in depressed adults and was considered to be partly the result of corticosteroid receptor downregulation (Zalsman, 2012) . This may be due to early and chronic high stress levels (Mann and Currier, 2011) . Early-life environmental stress increases the risk for suicidal behavior through developmental alterations in neurobiological systems (Brodsky and Stanley, 2008; Mann and Currier, 2010) and affects the stress response systems, for example, by DNA methylation (Ludwig et al., 2017; Mann and Currier, 2010) . McGowan et al. (2009) investigated postmortem hippocampi of suicide victims and found an increase in glucocorticoid receptor cytosine methylation and a reduced expression of glucocorticoid receptor mRNA and glucocorticoid receptor 1 F splice variant. They showed that the methylation status of suicide victims with childhood abuse entailed a decreased nerve growth factor-induced protein A (NGFI-A) transcription factor binding and NGFI-A gene transcription. This concept of early-life priming may be widened to include the intrauterine development. E.g., maternal psychosocial stress and cortisol levels during pregnancy correlate with larger newborns' cortisol response and a slower rate of behavioral recovery following the painful stress of a blood draw (Davis et al., 2011) . Elevated maternal cortisol during pregnancy was also associated with negative reactivity in 2 months old children (fear subscale of the Infant Temperament Questionnaire) (Davis et al., 2007) . Thus, early (including in utero) factors may cause silent alterations of the HPA axis with increased vulnerability to suicide later in life. In addition to stress, sex hormone effects might also account for epigenetic dysregulation in suicide. Estrogens, for example, inhibit DNA methyltransferase activity (Singh and Prasad, 2008) and the CAGn repeat polymorphism within the coding region of the androgen receptor has been associated with promoter methylation in peripheral blood (Muschler et al., 2014) .
A strong interaction between HPA and HPG axis is well-established. Gender dimorphisms in HPA axis reactivity support our assumption that androgen activity contributes to suicide completion. HPA axis response to dexamethasone (Pasquali et al., 2002 ) and the association with serotonin transporter availability (Tsai et al., 2012) are sex-dependent. Moreover, a higher cortisol response in the dexamethasone suppression / corticotropin releasing hormone stimulation test at admission predicts remission after 5 weeks of inpatient treatment in male but not female depressed patients. Notably, the cortisol response was not associated with blood sex hormone levels. The authors conclude that sex-related factors independent from activational peripheral sex hormones are involved in HPA axis reactivity in depression (Binder et al., 2009) . Accordingly, we speculate that in utero androgen activity organizes the HPA axis. Support for this hypothesis is provided by a study showing that low cortisol reactivity is related to more aggression in male adolescents with low 2D:4D ratios (i.e., high prenatal androgen load) but not in those with high 2D:4D ratios (Portnoy et al., 2015) .
Finally, maternal stress during pregnancy predicts lower 2D:4D ratios in boys and girls (Lenz et al., 2017) , lower 2D:4D ratios in nondomesticated field voles pups (Microtus agrestis) (Lilley et al., 2010) , and a longer anogenital distance in girls (= another biomarker for prenatal androgen exposure) (Barrett and Swan, 2015) . We have argued here that the 2D:4D ratio and prenatal androgen exposure are in general involved in suicide completion in adulthood. Thus, these studies Suominen et al. (2004); 9 suggest that maternal stress during pregnancy may represent an effective HPA axis-related target for suicide prevention in the future.
Lifetime androgen activity and the ideation-to-completion framework in suicide research
In Section 4, we introduced the ideation-to-completion framework in suicide research. For clinicians and other healthcare providers, it is particularly important to predict as accurately as possible which individuals will complete a suicide. To date, there is a lack of objective and reliable markers with sufficient specificity, sensitivity, and adequate positive predictive values. Based on the data reviewed above, we believe that prenatal and adult androgen activities, in combination with related biological and behavioral consequences, represent promising future predictors because they seem to be more specific to suicide completion than to suicidal ideation or suicide attempts. We proposed the androgen model of suicide completion and integrated organizational and activational androgen effects in the ideation-to-completion framework in suicide research. This may provide the basis for the development of selective and indicated suicide prevention strategies.
As previously discussed, the female gender and depressive disorders are more strongly associated with suicidal ideation and suicide attempts than with suicide completion. By contrast, male conditions that are linked to higher lifetime androgen activity appear to more specifically facilitate suicide completion (Table 1) . Fig. 3 shows several mechanisms that may underlie the association between higher lifetime androgen activity and suicide completion. Higher prenatal androgen exposure induces masculinized brain organization. It is suggested that increased prenatal androgen load also primes the endocrine system and thus sensitizes the individual to adult stressors with greater challenge-induced androgen spikes during adulthood. Moreover, adult androgen levels in neutral conditions activate cerebral androgen signaling.
We speculate that the interaction of these proandrogenic pathways provides the basis for increased vulnerability to suicide completion and for a reduced coping ability to protect against suicide completion. That is, prenatal androgen exposure promotes the development of vulnerabilities and impairs the development of coping abilities; additionally, adult androgen effects directly affect individuals who are more vulnerable and less resistant to stressor-induced suicides. As reviewed above, the hyperandrogenic male traits of a greater intention to die, the selection of more lethal suicide methods, aggression, violence, impulsivity, sensation seeking, cognitive reflection, lower BMI, substance use disorders, male depression, mixed depression, and a higher conformity to masculine norms may mediate the association between organizational and activational androgen activity and suicide completion. Moreover, a reduced behavioral repertoire of abilities that are necessary to successfully cope with suicide-inducing stressors may include socio-cognitive performance, social skills, personality, premeditation, and other factors.
Conclusions and perspectives
Completed suicides are dramatic and irreversible events that not only affect the suicide completers but also severely burden their friends, relatives, clinicians, and society. Clinicians and other healthcare providers often face the challenge of predicting which individuals will complete a suicide; because of the lack of reliable and objective markers with sufficient accuracy and positive predictive values, they must generally trust their intuition. Furthermore, knowledge of the mechanisms that facilitate the transition from suicidal ideation to suicide completion is limited and needs to be increased in the future.
In this review, we ascertained that the prediction of which individuals prospectively complete a suicide is most relevant and that future research on specific predictors of suicide completion is needed (ideation-to-completion framework in suicide research). These factors may significantly differ from predictors of suicidal ideation and suicide attempts. Several clinical lines of evidence suggest that androgen activity is related to suicide completion. Our review of the current literature demonstrates that both organizational and activational androgen effects are associated with suicide completion. However, our understanding of the detailed roles of organizational and activational
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Organization of the endocrine system with increased androgen spikes in challenging conditions B. Lenz et al. Progress in Neurobiology 172 (2019) [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] androgen activity and their interaction is incomplete. Future studies are needed to validate the reported findings and establish methods for how these and potential new biomarkers can be used sensibly in the daily routines of clinicians and other healthcare providers. Finally, the clarification of whether the androgen activity is causally related to suicide completion may provide the basis for novel preventive strategies. For this purpose, longitudinal studies (population-based and risk cohortspecific) need to be conducted. Moreover, future research into the determinants of prenatal androgen exposure is encouraged. It will be necessary to understand the extent to which maternal factors are responsible for the offspring's prenatal androgen exposure. For example, maternal smoking behavior, alcohol consumption, and stress levels are suggested modifiable determinants of children's intrauterine androgen loads (Barrett and Swan, 2015; Lenz et al., 2017; Lilley et al., 2010; Rizwan et al., 2007) . Future studies should investigate whether the modification of these maternal behavioral traits can reduce the fetuses' increased prenatal androgen exposure and thereby improve the offspring's subsequent mental health.
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